Surgery Doctors in Greenwood, SC Accepting Medicare

9 Surgery doctors found. Showing 1 - 9

Anas Abdel Azim, M.D., M.SC Surgery - Vascular Surgery Medicare: Accepting Medicare Assignments Practice Location: 160 Academy Ave, Greenwood, SC 29646 Phone: 864-223-8090    Fax: 864-223-4026

Edward Joseph Rapp Ii, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 105 Vinecrest Ct, Ste 500, Greenwood, SC 29646 Phone: 864-227-8932    Fax: 864-227-8973

Dr. Kevin Wright Carson, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 160 Academy Ave, Greenwood, SC 29646 Phone: 864-223-8090    Fax: 864-223-4026

Jeffrey E Lanford, MD Surgery - Vascular Surgery Medicare: Accepting Medicare Assignments Practice Location: 160 Academy Ave, Greenwood, SC 29646 Phone: 864-223-8090    Fax: 864-223-4026

John David Konsek, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 160 Academy Ave, Greenwood, SC 29646 Phone: 864-223-8090    Fax: 864-223-4026

Dr. Ryan Joseph Bolt, DO Surgery Medicare: Medicare Enrolled Practice Location: 160 Academy Ave, Greenwood, SC 29646 Phone: 864-223-8090

Dr. Jeffrey Bernard Thomas, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 160 Academy Ave, Greenwood, SC 29646 Phone: 864-223-8090

Francis Gregory Mappin, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 303 W Alexander Ave, Suite E, Greenwood, SC 29646 Phone: 864-725-7900

Scott W Gibson, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 160 Academy Ave, Greenwood, SC 29646 Phone: 864-223-8090    Fax: 864-223-4026

News Archive

Phase III PLATO study proves that ticagrelor is more effective than clopidogrel

New data from the phase III PLATO study showed that ticagrelor (BRILINTA((TM))) provided greater reduction of cardiovascular (CV) events (composite of CV death, heart attack and stroke) than clopidogrel (9.02% vs. 10.65%,>

Green tea shown to increase the defensive capabilities of cells

Green tea has been said to have a variety of health benefits. In this interview, we speak to Professor Micheal Ristow about his latest research into green tea.

Bortezomib reduces inflammation and promotes bone healing in arthritis models

A new study by Greek researchers suggests that the biologic drug bortezomib (Velcade), a proteasome inhibitor used to treat multiple myeloma (bone marrow cancer), may represent a promising treatment for rheumatoid arthritis (RA). In this study, bortezomib displayed favorable effects in an animal model of inflammatory arthritis that mimics RA, in reducing disease severity and inflammation, and promoting bone healing. Full findings of this study are published in the November issue of Arthritis & Rheumatism, a journal of the American College of Rheumatology (ACR).

Study: Lung squamous patients harboring druggable mutations have lower median overall survival

Oncotarget published "Molecular characterization of lung squamous cell carcinoma tumors reveals therapeutically relevant alterations" which reported that unlike lung adenocarcinoma patients, there is no FDA-approved targeted-therapy likely to benefit lung squamous cell carcinoma patients.

Domainex, Imperial College London expand collaboration to lessen cardiac muscle damage during heart attacks

Domainex Ltd. expands its partnership with Imperial College London, to discover novel therapies that reduce heart muscle damage during heart attacks. The aim is to discover a drug that inhibits the enzyme MAP4K4, which plays a key role in triggering cell death following a heart attack.

Read more Medical News

› Verified 7 days ago